The FIB4, a readily calculable composite marker incorporating age, platelet count, and hepatic transaminases (ALT/AST), has garnered attention for its dual role in evaluating hepatic fibrosis and systemic metabolic dysregulation [3]. Here, GPT is linked to Hepatic fibrosis.